Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1155/2018/5917470 http://scihub22266oqcxt.onion/10.1155/2018/5917470 C6038689!6038689!30046513     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Anal+Cell+Pathol+(Amst) 2018 ; 2018 (ä): ä Nephropedia Template TP {{tp|p=30046513|t=2018. Metformin Treatment Inhibits Motility and Invasion of Glioblastoma Cancer Cells |pdf=|usr=}}{{30046513}} gab.com Text Metformin Treatment Inhibits Motility and Invasion of Glioblastoma Cancer Cells JO: Anal Cell Pathol (Amst) http://www.kidney.de/pget.php?&tw=1&pmid=30046513 #FOAvip Glioblastoma multiforme (GBM) is one of the most common and deadliest cancers of the central nervous system (CNS). GBMs high ability to infiltrate healthy brain tissues makes it difficult to remove surgically and account for its fatal outcomes. To improve the chances of survival, it is critical to screen for GBM-targeted anticancer agents with anti-invasive and antimigratory potential. Metformin, a commonly used drug for the treatment of diabetes, has recently emerged as a promising anticancer molecule. This prompted us, to investigate the anticancer potential of metformin against GBMs, specifically its effects on cell motility and invasion. The results show a significant decrease in the survival of SF268 cancer cells in response to treatment with metformin. Furthermore, metformin's efficiency in inhibiting 2D cell motility and cell invasion in addition to increasing cellular adhesion was also demonstrated in SF268 and U87 cells. Finally, AKT inactivation by downregulation of the phosphorylation level upon metformin treatment was also evidenced. In conclusion, this study provides insights into the anti-invasive antimetastatic potential of metformin as well as its underlying mechanism of action. Twit Text FOAVip Metformin Treatment Inhibits Motility and Invasion of Glioblastoma Cancer Cells ????Anal Cell Pathol (Amst) http://www.kidney.de/pget.php?&tw=1&pmid=30046513 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=30046513 #FOAvip English Wikipedia <ref>{{Cite pmid|30046513}}</ref> Metformin Treatment Inhibits Motility and Invasion of Glioblastoma Cancer Cells #MMPMID30046513 Al Hassan M; Fakhoury I; El Masri Z; Ghazale N; Dennaoui R; El Atat O; Kanaan A; El-Sibai M Anal Cell Pathol (Amst) 2018[]; 2018 (ä): ä PMID30046513show ga Glioblastoma multiforme (GBM) is one of the most common and deadliest cancers of the central nervous system (CNS). GBMs high ability to infiltrate healthy brain tissues makes it difficult to remove surgically and account for its fatal outcomes. To improve the chances of survival, it is critical to screen for GBM-targeted anticancer agents with anti-invasive and antimigratory potential. Metformin, a commonly used drug for the treatment of diabetes, has recently emerged as a promising anticancer molecule. This prompted us, to investigate the anticancer potential of metformin against GBMs, specifically its effects on cell motility and invasion. The results show a significant decrease in the survival of SF268 cancer cells in response to treatment with metformin. Furthermore, metformin's efficiency in inhibiting 2D cell motility and cell invasion in addition to increasing cellular adhesion was also demonstrated in SF268 and U87 cells. Finally, AKT inactivation by downregulation of the phosphorylation level upon metformin treatment was also evidenced. In conclusion, this study provides insights into the anti-invasive antimetastatic potential of metformin as well as its underlying mechanism of action. äMetformin Treatment Inhibits Motility and Invasion of Glioblastoma Can(epmc).pdf DeepDyve Pubget Overpricing